Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide originally isolated from the porcine duodenum, classified within a family of regulatory peptides that includes glucagon and secretin. Researchers primarily study VIP for its roles as a neurotransmitter and hormone, particularly in the regulation of various physiological processes such as digestion, cardiac activity, and neuroendocrine functions. Key findings indicate that VIP is involved in modulating brain activity and may act as a neuronal survival factor, with its expression regulated by both neuronal and endocrine signals. Furthermore, studies have highlighted significant species differences in VIP pharmacophore interactions with its receptors, suggesting the need for careful consideration in the design of VIP analogs for therapeutic applications. Current research continues to explore VIP's potential in treating neurological disorders and its mechanisms of action in various biological systems.